Diagnostic modalities for nonalcoholic fatty liver disease, nonalcoholic steatohepatitis, and associated fibrosis

M. Younossi, Zobair; Loomba, Rohit; M. Anstee, Quentin; E. Rinella, Mary; Bugianesi, Elisabetta; Marchesini, Giulio; A. Neuschwander‐Tetri, Brent; Serfaty, Lawrence; Negro, Francesco; H. Caldwell, Stephen; Ratziu, Vlad; E. Corey, Kathleen; L. Friedman, Scott; F. Abdelmalek, Manal; A. Harrison, Stephen; J. Sanyal, Arun; E. Lavine, Joel; Mathurin, Philippe; Charlton, Michael; Goodman, Zachary; P. Chalasani, Naga; V. Kowdley, Kris; George, Jacob; D. Lindor, Keith

doi:10.1002/hep.29721

Public

Diagnostic modalities for nonalcoholic fatty liver disease, nonalcoholic steatohepatitis, and associated fibrosis

Published in Hepatology • Dec 9, 2017

Authors:

Zobair M. Younossi

Rohit Loomba

Quentin M. Anstee

Abstract

Nonalcoholic fatty liver disease (NAFLD) is a spectrum comprised of isolated steatosis, nonalcoholic steatohepatitis (NASH), advanced fibrosis, and cirrhosis. The majority of NAFLD subjects do not have NASH and do not carry a significant risk for liver-related adverse outcomes (cirrhosis and mortali...

Subject

Nonalcoholic fatty liver disease

Transient elastography

Cirrhosis

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!